First Time Loading...
Q

Quoin Pharmaceuticals Ltd
NASDAQ:QNRX

Watchlist Manager
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Watchlist
Price: 0.7771 USD 10.86% Market Closed
Updated: Jun 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

16.1m
+32%
Assets
Growth Rates:
1 Year
-13%
3 Years
+613%
5 Years
+50%
7 Years
-
10 Years
-
7m
+8%
Liabilities
Growth Rates:
1 Year
-7%
3 Years
-45%
5 Years
+48%
7 Years
-
10 Years
-
9.1m
+61%
Equity
Growth Rates:
1 Year
-16%
3 Years
-
5 Years
+51%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Quoin Pharmaceuticals Ltd

16.1m
Assets
7m
Liabilities
16.1m
Assets
7m
Liabilities
Current Assets 15.3m
Cash & Short-Term Investments 14.7m
Other Current Assets 574.9k
Non-Current Assets 858.3k
Intangibles 558.3k
Other Non-Current Assets 300k
Current Liabilities 4.2m
Accounts Payable 358.5k
Accrued Liabilities 3.3m
Short-Term Debt 600k
Non-Current Liabilities 2.8m
Long-Term Debt 2.8m

Balance Sheet
Quoin Pharmaceuticals Ltd

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
5
5
5
7
3
2
Cash
0
0
0
7
3
2
Cash Equivalents
5
5
5
0
0
0
Short-Term Investments
0
0
0
0
10
8
Total Receivables
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
Other Current Assets
0
0
0
1
1
1
Total Current Assets
5
5
5
9
13
11
PP&E Net
0
1
1
0
0
0
Intangible Assets
0
0
0
1
1
1
Note Receivable
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
Total Assets
6
N/A
6
+12%
6
-1%
9
+53%
14
+54%
12
-16%
Liabilities
Accounts Payable
1
1
1
1
1
1
Accrued Liabilities
0
0
0
3
2
2
Short-Term Debt
0
0
0
0
1
1
Current Portion of Long-Term Debt
0
0
0
1
0
0
Other Current Liabilities
0
0
0
0
0
0
Total Current Liabilities
1
1
1
5
4
4
Long-Term Debt
0
0
0
4
4
3
Other Liabilities
0
1
0
0
0
0
Total Liabilities
2
N/A
2
+4%
1
-24%
9
+508%
7
-19%
7
-8%
Equity
Common Stock
0
0
0
0
0
0
Retained Earnings
19
24
32
28
38
46
Additional Paid In Capital
25
31
40
32
48
52
Treasury Stock
3
3
3
3
3
0
Total Equity
4
N/A
4
+15%
5
+9%
1
-86%
7
+1 023%
6
-24%
Total Liabilities & Equity
6
N/A
6
+12%
6
-1%
9
+53%
14
+54%
12
-16%
Shares Outstanding
Common Shares Outstanding
1
1
3
279
2 019
1

See Also

Summary
QNRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
QNRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
QNRX stock valuation using valuation multiples.
Wall Street Estimates
QNRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
QNRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 143,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.